Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Indivior (Nasdaq: INDV) will report its third quarter 2025 financial results on Thursday, October 30, 2025 at 7:00 a.m. U.S. ET. Following the release, CEO Joe Ciaffoni and other leaders will host a live webcast presentation at 8:00 a.m. U.S. ET. The live webcast and presentation materials will be available on the company's Investors page at www.indivior.com, with a live webcast link and telephone registration option provided for participants. A replay of the presentation will be posted on www.indivior.com after the event.
Details
News Market Reaction – INDV
On Oct 17, the first trading day after this news, INDV closed 0.85% below the previous close.
Data tracked by StockTitan Argus for the Oct 17 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins.
Live Q3 2025 webcast link: https://edge.media-server.com/mmc/p/gtkfqvez
Participants may access the presentation telephonically by registering with the following link:
https://register-conf.media-server.com/register/BI470cbb79a42846d5b6b180de536bbf66
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com.
About Indivior
Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-report-third-quarter-2025-financial-results-and-host-webcast-on-october-30th-302586816.html
SOURCE Indivior PLC
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.